Human Investing LLC Decreases Stock Position in Amdocs Limited (NASDAQ:DOX)

Human Investing LLC cut its stake in shares of Amdocs Limited (NASDAQ:DOX) by 8.8% in the 3rd quarter, HoldingsChannel reports. The fund owned 5,508 shares of the technology company’s stock after selling 529 shares during the quarter. Human Investing LLC’s holdings in Amdocs were worth $482,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Rice Hall James & Associates LLC boosted its stake in shares of Amdocs by 338.3% during the third quarter. Rice Hall James & Associates LLC now owns 167,023 shares of the technology company’s stock valued at $14,611,000 after purchasing an additional 128,919 shares during the period. Deroy & Devereaux Private Investment Counsel Inc. raised its holdings in Amdocs by 1.0% during the 3rd quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 299,250 shares of the technology company’s stock valued at $26,178,000 after buying an additional 2,890 shares during the last quarter. First Trust Direct Indexing L.P. boosted its position in Amdocs by 7.0% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 3,063 shares of the technology company’s stock valued at $268,000 after buying an additional 200 shares during the period. GW Henssler & Associates Ltd. bought a new stake in Amdocs in the 3rd quarter worth $6,665,000. Finally, Strategic Wealth Investment Group LLC increased its position in shares of Amdocs by 13.3% in the third quarter. Strategic Wealth Investment Group LLC now owns 12,984 shares of the technology company’s stock valued at $1,135,000 after acquiring an additional 1,520 shares during the period. 92.02% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on DOX. Stifel Nicolaus initiated coverage on Amdocs in a research note on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 target price on the stock. StockNews.com upgraded Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Friday, October 25th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Amdocs presently has an average rating of “Buy” and a consensus price target of $102.00.

Amdocs Trading Up 0.3 %

Shares of NASDAQ DOX traded up $0.30 during midday trading on Friday, hitting $88.05. 37,519 shares of the company traded hands, compared to its average volume of 669,042. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.24 and a current ratio of 1.24. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04. The stock has a 50-day moving average price of $87.36 and a 200 day moving average price of $83.65. The firm has a market cap of $10.35 billion, a P/E ratio of 20.22, a P/E/G ratio of 1.43 and a beta of 0.74.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Wednesday, August 7th. The technology company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.60 by $0.02. The business had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.25 billion. Amdocs had a return on equity of 17.89% and a net margin of 10.21%. The company’s revenue for the quarter was up 1.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.41 earnings per share. As a group, analysts expect that Amdocs Limited will post 5.67 earnings per share for the current year.

Amdocs Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Monday, September 30th were paid a dividend of $0.479 per share. This represents a $1.92 annualized dividend and a yield of 2.18%. The ex-dividend date of this dividend was Monday, September 30th. Amdocs’s payout ratio is currently 44.24%.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.